A retrospective study to determine experience with elotuzumab-based maintenance following autologous stem cell transplant in MM patients
Latest Information Update: 11 Jun 2021
At a glance
- Drugs Elotuzumab (Primary) ; Bortezomib; Dexamethasone; Lenalidomide; Methylprednisolone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 11 Jun 2021 New trial record